DGAP-News: ABIVAX / Key word(s): Study 30.11.2020 / 19:00 The issuer is solely responsible for the content of this announcement.
Abivax completes recruitment of ABX464 Phase 2b induction study in ulcerative colitis
PARIS, November 30, 2020 - 7:00 p.m. (CET) - Abivax (Euronext Paris: FR0012333284 - ABVX), a clinical-stage biotechnology company harnessing the immune system to develop novel treatments for inflammatory diseases, viral diseases and cancer, announced today the completion of recruitment for its Phase 2b induction study for the lead candidate ABX464 for the treatment of patients with moderate-to-severe ulcerative colitis. This study exceeded industry standard recruitment rates for UC, during the Covid-19 crisis, by utilizing the experience, relationships and data built by working across many UC studies with sites, in tandem with innovative recruitment solutions. The randomization of the targeted 232 patients has been completed ahead of schedule, with minimal impact of the Covid-19 pandemic on the pace of recruitment. Top-line results of the Phase 2b UC induction study, conducted in 15 European countries, Canada and the US, are expected to be available in Q2 2021.
"The completion of recruitment of the Phase 2b induction study in ulcerative colitis with ABX464, our lead clinical program, is a critical milestone for Abivax. We are very pleased that patients enrolled so rapidly into the trial, despite the Covid-19 pandemic.", said Paul Gineste, Pharm D., VP Clinical Operations of Abivax, and he continued: "I would particularly like to thank our very committed investigators, our CRO, IQVIA, and our clinical team who made this possible, despite challenging circumstances. We are now looking forward to the high-level data that we expect will become available in Q2 2021."
Prof. Hartmut J. Ehrlich, M.D., CEO of Abivax, added: "With the financial resources of EUR 84m we secured over the past six months, Abivax is able to go full speed in advancing ABX464 into a pivotal Phase 2b/3 study in Crohn's disease and to prepare for the Phase 3 clinical program in UC. With ABX464 as a novel treatment with durable efficacy and a good safety profile observed in studies performed, we hope to make a real difference for patients suffering from the devastating consequences of inflammatory bowel diseases, as well as potentially other chronic inflammatory diseases."
The Phase 2b induction study in patients with moderate-to-severe UC (ABX464-103), enrolled the first patient in August 2019. In addition, Abivax initiated a companion long-term open-label maintenance study (ABX464-104) in which patients who have completed the induction study were eligible to continue the treatment to further investigate the long-term safety and efficacy profile of ABX464. 130 out of 132 patients, who completed the induction study, have been enrolled to date into the maintenance study that has been expanded for a second year.
The Company communicated positive results of the previous Phase 2a induction study in UC in September 2018, followed by additional positive data from the 12-month open label Phase 2a maintenance study presented at the UEG Conference in October 2019. Recently, these positive long-term data were further confirmed following results from two years dosing of 50mg ABX464 in which 69% of patients were in clinical remission and 94% benefited from a clinical response.
Prof. Sverine Vermeire, M.D., Ph.D., Head of the IBD Center at the University Hospitals Leuven, Belgium, and principal investigator of the study, said: "Given the promising results so far, I am looking forward to see data from this Phase 2b induction study and I hope that they will once again confirm the safety and durability of clinical efficacy of ABX464 in UC patients, already observed in the Phase 2a study. Ulcerative colitis is a very disabling disease for patients and the need for a durable and efficacious treatment is still very high."
Alistair Grenfell, President, IQVIA EMEA, said: "IQVIA is proud to have been selected as the CRO partner of Abivax for the ABX464 induction and maintenance studies in ulcerative colitis. We are delighted to see the use of our unique CORE Powered capabilities helped Abivax complete recruitment ahead of plan and despite the Covid-19 pandemic challenges. We look forward to continuing the study with Abivax and the investigational sites to manage the clinical data and deliver high quality study results in Q2 2021."
Update on Abivax's additional ongoing clinical trials Abivax's Phase 2a proof of concept clinical trial with ABX464 in rheumatoid arthritis is progressing according to plan with top-line results of the induction study to be communicated in Q2 2021.
The Phase 2b/3 clinical trial of ABX464 in Covid-19 patients is ongoing in Europe and Latin America and top-line results are expected in Q1 2021, subject to the evolution of the pandemic.
The clinical Phase 1/2 study with Abivax's second clinical candidate, ABX196, in hepatocellular carcinoma which is being conducted in the US is also progressing, despite the Covid-19 situation.
About Abivax (www.abivax.com) Abivax, a clinical stage biotechnology company, is mobilizing the body's natural immune machinery to treat patients with chronic inflammatory diseases, viral infections, and cancer. Abivax is listed on Euronext compartment C (ISIN: FR0012333284 - Mnmo: ABVX). Based in Paris and Montpellier, Abivax has two drug candidates in clinical development, ABX464 to treat severe inflammatory diseases, and ABX196 to treat hepatocellular carcinoma. More information on the company is available at http://www.abivax.com. Follow us on Twitter @ABIVAX_.
About IQVIA IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions and contract research services to the life sciences industry. Formed through the merger of IMS Health and Quintiles, IQVIA applies Human Data Science - leveraging the analytic rigor and clarity of data science to the ever-expanding scope of human science - to enable companies to reimagine and develop new approaches to clinical development and commercialization, speed innovation and accelerate improvements in healthcare outcomes. Powered by the IQVIA CORE(TM), IQVIA delivers unique and actionable insights at the intersection of large-scale analytics, transformative technology and extensive domain expertise, as well as execution capabilities. With approximately 67,000 employees, IQVIA conducts operations in more than 100 countries.
IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA's insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit http://www.iqvia.com.
******
Contacts
DISCLAIMER
This press release contains forward-looking statements, forecasts and estimates (including patient recruitment) with respect to certain of the Company's programs. Although the Company believes that its forward-looking statements, forecasts and estimates are based on assumptions and assessments of known and unknown risks, uncertainties and other factors that have been deemed reasonable, such forward-looking statements, forecasts and estimates are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated in such forward-looking statements, forecasts and estimates. A description of these risks, contingencies and uncertainties can be found in the documents filed by the Company with the French Autorit des Marchs Financiers pursuant to its legal obligations including its registration document (Document d'Enregistrement Universel). Furthermore, these forward-looking statements, forecasts and estimates are only as of the date of this press release. Readers are cautioned not to place undue reliance on these forward-looking statements. Abivax disclaims any obligation to update these forward-looking statements, forecasts or estimates to reflect any subsequent changes that the Company becomes aware of, except as required by law. This press release is for information purposes only, and the information contained herein does not constitute either an offer to sell, or the solicitation of an offer to purchase or subscribe securities of the Company in any jurisdiction, in particular in France. Similarly, it does not give and should not be treated as giving investment advice. It has no connection with the investment objectives, financial situation or specific needs of any recipient. It should not be regarded by recipients as a substitute for exercise of their own judgement. All opinions expressed herein are subject to change without notice. The distribution of this document may be restricted by law in certain jurisdictions. Persons into whose possession this document comes are required to inform themselves about and to observe any such restrictions.
30.11.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at http://www.dgap.de
See the rest here:
Abivax completes recruitment of ABX464 Phase 2b induction study in ulcerative colitis - PharmiWeb.com
- GW Pharma Reports Preliminary Topline Results Of Ulcerative Colitis Trial - October 15th, 2014 [October 15th, 2014]
- Ulcerative Colitis: Facts on Symptoms, Treatment and Diet - October 15th, 2014 [October 15th, 2014]
- Ulcerative Colitis - National Digestive Diseases ... - October 15th, 2014 [October 15th, 2014]
- CCFA: What is Ulcerative Colitis | Inflammatory Bowel Disease - October 15th, 2014 [October 15th, 2014]
- Ulcerative Colitis: Get Facts on Symptoms and Diet - October 15th, 2014 [October 15th, 2014]
- Ulcerative colitis - Wikipedia, the free encyclopedia - October 15th, 2014 [October 15th, 2014]
- Ulcerative Colitis Testimonial - Video - October 15th, 2014 [October 15th, 2014]
- My Fight With Ulcerative Colitis - Video - October 15th, 2014 [October 15th, 2014]
- Diet in Ulcerative Colitis - Best and Worst Foods - Video - October 15th, 2014 [October 15th, 2014]
- Why Ulcerative Colitis is (Literally) a Pain in the Butt - Video - October 15th, 2014 [October 15th, 2014]
- My Journey= Ulcerative Colitis Proctitis PART 1 - Video - October 15th, 2014 [October 15th, 2014]
- Top 15 Ways to Cure Ulcerative Colitis Naturally - Diet & Home Remedies - Video - October 15th, 2014 [October 15th, 2014]
- Updates in Ulcerative Colitis & Crohn's disease - October 17th, 2014 [October 17th, 2014]
- Ulcerative colitis Symptoms - Diseases and Conditions ... - October 17th, 2014 [October 17th, 2014]
- Dr. Morse Explains Ulcerative Colitis and Intestinal Conditions - Video - October 20th, 2014 [October 20th, 2014]
- Depression Stress Anxiety IBS Colitis Arthritis Treatment Allergy Testing Reiki Healing Scotland W - Video - October 20th, 2014 [October 20th, 2014]
- Taylor Healing process - Video - October 20th, 2014 [October 20th, 2014]
- Treating Pediatric Inflammatory Bowel Disease - Video - October 20th, 2014 [October 20th, 2014]
- Take Steps Walk for Crohn's and Colitis - Video - October 21st, 2014 [October 21st, 2014]
- Ulcerative Colitis & Me - Video - October 21st, 2014 [October 21st, 2014]
- Ferring Pharmaceuticals: CORTIMENT MMX, a new treatment for ulcerative colitis, receives European approval - October 22nd, 2014 [October 22nd, 2014]
- Sleep duration affects risk for ulcerative colitis - October 22nd, 2014 [October 22nd, 2014]
- My Journey= Ulcerative Colitis Proctitis PART#3 - Video - October 23rd, 2014 [October 23rd, 2014]
- Added benefit of vedolizumab is not proven - October 24th, 2014 [October 24th, 2014]
- My Journey= Ulcerative Colitis Proctitis PART#2 - Video - October 24th, 2014 [October 24th, 2014]
- Why Food Network Star Sunny Anderson Can't Eat Vegetables - October 24th, 2014 [October 24th, 2014]
- New compounds reduce debilitating inflammation - October 26th, 2014 [October 26th, 2014]
- Sleep Duration Linked to Ulcerative Colitis Risk in Study - October 27th, 2014 [October 27th, 2014]
- Ulcerative colitis: MedlinePlus Medical Encyclopedia - October 27th, 2014 [October 27th, 2014]
- Ulcerative Colitis - American Society of Colon and Rectal ... - October 27th, 2014 [October 27th, 2014]
- NHS Ulcerative Colitis - NHS Choices - Your health, your ... - October 27th, 2014 [October 27th, 2014]
- Ulcerative Colitis - October 27th, 2014 [October 27th, 2014]
- How to heal intestines | Ulcerative Colitis | SCD Lifestyle - Video - October 27th, 2014 [October 27th, 2014]
- Ulcerative Colitis - Causes, Symptoms, Diet & Herbal Remedies in Punjabi - Video - October 27th, 2014 [October 27th, 2014]
- Receptos: good results for ulcerative colitis drug - October 29th, 2014 [October 29th, 2014]
- Should I Drink Alcohol if I Have Crohn's Disease or Ulcerative Colitis - Video - October 29th, 2014 [October 29th, 2014]
- New clinical trial data: Multiple sclerosis drug candidate also shows promise for ulcerative colitis - October 30th, 2014 [October 30th, 2014]
- TSRI's MS Drug Also Shows Promise In Ulcerative Colitis - November 1st, 2014 [November 1st, 2014]
- Justin Mirigliani repping 260lbs on the Bench! Never Surrender! Fighting Ulcerative Colitis! - Video - November 1st, 2014 [November 1st, 2014]
- Managing Ulcerative Colitis Naturally: Outlook & Perspective - Video - November 1st, 2014 [November 1st, 2014]
- My Ulcerative Colitis Diet - Video - November 1st, 2014 [November 1st, 2014]
- Healing my Ulcerative Colitis - Video - November 2nd, 2014 [November 2nd, 2014]
- Peoria Connections Interview - Successes with autoimmune disease, ADHD, ulcerative colitis - Video - November 2nd, 2014 [November 2nd, 2014]
- Crohns Disease & Ulcerative Colitis The Diagnosing Difficulties - Video - November 2nd, 2014 [November 2nd, 2014]
- My Ulcerative Colitis Story - Video - November 3rd, 2014 [November 3rd, 2014]
- Pudge Rodriguez will be special guest at Crohns and Colitis Foundation dinner - November 4th, 2014 [November 4th, 2014]
- Diagnosing Crohns Disease & Ulcerative Colitis - Video - November 4th, 2014 [November 4th, 2014]
- Natural Treatment for Ulcerative Colitis with Causes and Symptoms - Video - November 5th, 2014 [November 5th, 2014]
- Acute Severe Ulcerative Colitis - Video - November 5th, 2014 [November 5th, 2014]
- CME Outfitters and USF Health to Host Medical Symposium in Conjunction with the 2014 Advances in IBD Crohns & Colitis ... - November 7th, 2014 [November 7th, 2014]
- How sleep affects my Ulcerative Colitis Symptoms - Video - November 7th, 2014 [November 7th, 2014]
- Healing my Ulcerative Colitis Webcam video from November 4, 2014 05:49 PM - Video - November 7th, 2014 [November 7th, 2014]
- Managing Extra-Intestinal Manifestations of Crohn's Disease & Ulcerative Colitis - Video - November 7th, 2014 [November 7th, 2014]
- Causes and Treatment of Crohns Disease and Ulcerative Colitis - Video - November 8th, 2014 [November 8th, 2014]
- How to stop the Cause of IBS, Crohn's and Ulcerative Colitis - Video - November 8th, 2014 [November 8th, 2014]
- Introduction to Ulcerative Colitis - Video - November 8th, 2014 [November 8th, 2014]
- Ulcerative Colitis Dr Tehsina0 - Video - November 8th, 2014 [November 8th, 2014]
- Taking Steps Against Crohn's and Colitis - November 9th, 2014 [November 9th, 2014]
- How To Make Chicken 3 Ways + Gut Healing Bone Broth - by Thyroid Loving Care - Video - November 10th, 2014 [November 10th, 2014]
- Ileal Pouch - Anal Anastomosis in Chronic Ulcerative Colitis - Video - November 10th, 2014 [November 10th, 2014]
- Vlog #1 - November 10 2014 - Video - November 11th, 2014 [November 11th, 2014]
- Ulcerative Colitis Patient Success Story - Video - November 11th, 2014 [November 11th, 2014]
- How to Recover from Ulcerative Colitis - Video - November 12th, 2014 [November 12th, 2014]
- Vlog #2 - November 11, 2014 - Living with Ulcerative Colitis - Video - November 13th, 2014 [November 13th, 2014]
- How IBD (Crohn's Disease and Ulcerative Colitis) Affects Mental Health - Video - November 15th, 2014 [November 15th, 2014]
- Ulcerative Colitis Got Me Down - Video - November 15th, 2014 [November 15th, 2014]
- Surgeon Spotlight: Dr. Amit Merchea - Chronic Ulcerative Colitis - Video - November 16th, 2014 [November 16th, 2014]
- Ulcerative Colitis Proctitis: Doctor Update, Medications - Video - November 16th, 2014 [November 16th, 2014]
- Ulcerative Colitis Got You Down Too? - Video - November 16th, 2014 [November 16th, 2014]
- Management of ulcerative colitis - Wikipedia, the free ... - November 17th, 2014 [November 17th, 2014]
- IBD Support Group: Crohn's Disease and Ulcerative Colitis - November 17th, 2014 [November 17th, 2014]
- Crohn's Disease, Ulcerative Colitis and the Team Challenge endurance training program - Video - November 17th, 2014 [November 17th, 2014]
- Let's CRUSH Ulcerative Colitis LIke a Coke Can - Video - November 19th, 2014 [November 19th, 2014]
- 21 Weeks Pregnant Update! - Ultrasound & Ulcerative Colitis - Video - November 20th, 2014 [November 20th, 2014]
- Healing my Ulcerative Colitis Webcam video from November 17, 2014 02:48 PM - Video - November 20th, 2014 [November 20th, 2014]
- Is Crohns Disease or Ulcerative Colitis Hereditary? - Video - November 22nd, 2014 [November 22nd, 2014]
- Celebrity chef Sunny Anderson on living with irritable bowel disease - November 23rd, 2014 [November 23rd, 2014]
- 13 Years with Ulcerative Colitis - Video - November 26th, 2014 [November 26th, 2014]
- Mark: Healed of Ulcerative Colitis - Video - November 26th, 2014 [November 26th, 2014]
- Colonoscopy of Ulcerative Colitis - Video - November 30th, 2014 [November 30th, 2014]